Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Yemen Health Report.
Press releases published on August 20, 2025
Global Enzymes Market Set to Reach $20.4 Billion by 2029 | Asia-Pacific Emerges as a Hotspot
GlobeNewswire
·
August 20, 2025
Delray Beach, FL, Aug. 20, 2025 (GLOBE NEWSWIRE) -- According to MarketsandMarkets, the global enzymes market is experiencing robust growth, driven by innovations in biotechnology, increasing demand in biopharmaceutical production, and rising environmental …
BioAge Labs to Present at Upcoming Investor Conferences
GlobeNewswire
·
August 20, 2025
EMERYVILLE, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) ("BioAge", "the Company"), a clinical-stage biotechnology company developing therapeutic product candidates for metabolic diseases by targeting the biology of human …
Olema Oncology to Participate in Upcoming Investor Conferences
GlobeNewswire
·
August 20, 2025
SAN FRANCISCO, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema”, or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for …
Sana Biotechnology Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares
GlobeNewswire
·
August 20, 2025
SEATTLE, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (Nasdaq: SANA) (“Sana”), a company focused on changing the possible for patients through engineered cells, today announced that it has closed the sale of 3,358,208 shares of its common …
NurExone Biologic Announces Preclinical Evidence of Structural Repair in Injured Spinal Cord Tissue following ExoPTEN Treatment
GlobeNewswire
·
August 20, 2025
TORONTO and HAIFA, Israel, Aug. 20, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) is pleased to announce new preclinical imaging results providing anatomical evidence consistent with …
Zealand Pharma major shareholder announcement: Van Herk Investments B.V.
GlobeNewswire
·
August 20, 2025
Company announcement – No. 19 / 2025 Zealand Pharma major shareholder announcement: Van Herk Investments B.V. Copenhagen, Denmark, August 20, 2025 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the …
2030 financial targets announced: Organic sales growth acceleration, margin expansion and ROIC improvement
GlobeNewswire
·
August 20, 2025
COPENHAGEN, Denmark - August 20, 2025. Novonesis today announces its ‘GROW’ strategy and long-term targets for the strategy period until 2030 focusing on an acceleration of the core business and significant re-investments to secure long-term growth. By …
Global Big Data in Healthcare Market is Predicted to Cross the USD 330 Billion Mark by 2032 | DelveInsight
GlobeNewswire
·
August 20, 2025
New York, USA, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Global Big Data in Healthcare Market is Predicted to Cross the USD 330 Billion Mark by 2032 | DelveInsight The demand for big data in healthcare is growing rapidly, fueled by the rising incidence of chronic …
Merkel Cell Carcinoma Market Set for Rapid Growth in the Coming 10 Years Across the 7MM | DelveInsight
GlobeNewswire
·
August 20, 2025
New York, USA, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Merkel Cell Carcinoma Market Set for Rapid Growth in the Coming 10 Years Across the 7MM | DelveInsight The market size of Merkel cell carcinoma in the 7MM is expected to increase during the forecast period ( …
King Faisal Specialist Hospital Provides Nearly 300,000 Virtual Consultations in 2024
GlobeNewswire
·
August 20, 2025
RIYADH, Saudi Arabia, Aug. 20, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSHRC) delivered 293,381 virtual clinic visits in 2024, a 58.2% increase from the previous year. The growth highlights how telehealth has become …
OSE Immunotherapeutics nomme Thomas Gidoin au poste de Directeur Financier
GlobeNewswire
·
August 20, 2025
NANTES, France - 20 août 2025, 18 h 00 – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), annonce aujourd’hui la nomination de Thomas Gidoin au poste de Directeur Financier. Thomas rejoint le Comité Exécutif, apportant à la Société plus de 15 …
BioAdaptives’ MyndMed™ Receives Full Clearance from TruShield™, Meeting UFC and WADA Standards for Athlete Safety
GlobeNewswire
·
August 20, 2025
LAS VEGAS, Aug. 20, 2025 (GLOBE NEWSWIRE) -- via IBN – BioAdaptives, Inc. (OTCMKTS: BDPT), a leader in natural health and performance supplements, today announced that its flagship nootropic formula, MyndMed™, has been officially certified clean by …
BioAegis Therapeutics Awarded Second FDA Fast Track Designation for Recombinant Human Gelsolin to Treat Inflammasome-Driven Decompression Sickness (DCS)
GlobeNewswire
·
August 20, 2025
Fast Track status accelerates regulatory pathway for BioAegis’ recombinant human plasma gelsolin (rhu-pGSN), a novel immune modulator for inflammatory diseases. Second Fast Track designation in recent months highlights broad potential of rhu-pGSN across …
Keros Announces U.S. FDA Orphan Drug Designation Granted to KER-065 for the Treatment of Duchenne Muscular Dystrophy
GlobeNewswire
·
August 20, 2025
LEXINGTON, Mass., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders …
Sustainability & Nutrition Drives Pea Protein Market Expansion | Europe Leads Global Market Growth
GlobeNewswire
·
August 20, 2025
Delray Beach, FL, Aug. 20, 2025 (GLOBE NEWSWIRE) -- According to a recent research report published by MarketsandMarkets, the pea protein market was valued at USD 2.1 billion in 2024 and projected to reach USD 3.7 billion by 2029, growing at a robust CAGR …
Noble Capital Markets Initiates Equity Research Coverage on Greenwich LifeSciences
GlobeNewswire
·
August 20, 2025
STAFFORD, Texas, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy …
Longeveron® to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
August 20, 2025
MIAMI, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening, rare pediatric and chronic aging-related conditions, today announced …
Calidi Biotherapeutics Announces Pricing of $6 Million Underwritten Public Offering
GlobeNewswire
·
August 20, 2025
SAN DIEGO, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic …
American Kidney Fund Launches Podcast, 'The Kidney Collective'
GlobeNewswire
·
August 20, 2025
ROCKVILLE, Md., Aug. 20, 2025 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) is proud to announce the launch of its first-ever podcast, "The Kidney Collective™." Introduced as a seven-episode, limited series, The Kidney Collective gives an intimate …
Regulatory Approval Granted for Commencement of Trinity Biotech’s Offshored and Outsourced Manufacturing of its Flagship Rapid HIV Test, Facilitating Strategic and Financial Performance Transformation
GlobeNewswire
·
August 20, 2025
Approval Facilitates Immediate Offshored and Outsourced Manufacturing Strategic Offshore Manufacturing Move Expected to Drive Gross Margin Expansion, Free Up Working Capital, and Enhance Scalability Transition to Outsourced Production Reduces Fixed Costs …